https://adisinsight.springer.com/trials/700374533?error=cookies_not_supported&code=3da7de1e-59a7-4fd4-972e-dde8587e7299
A Study of AK112 Monotherapy in Advanced/Metastatic Renal Cell Carcinoma - AdisInsight
This is an open-label, single arm , Ib/II phase trial to evaluate the efficacy and safety of AK112 ivonescimab monotherapy as first-line treatment for
renal cell carcinoma